These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21881847)

  • 21. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
    Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
    Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the potential utility of a linomide analogue for treatment of choroidal neovascularization.
    Abdel-Rahman MH; Yang Y; Salem MM; Meadows S; Massengill JB; Li PK; Davidorf FH
    Exp Eye Res; 2010 Dec; 91(6):837-43. PubMed ID: 21055400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops.
    Zhang X; Li Y; Cheng Y; Tan H; Li Z; Qu Y; Mu G; Wang F
    Biochim Biophys Acta; 2015 Jun; 1850(6):1140-9. PubMed ID: 25662072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis.
    Sui A; Zhong Y; Demetriades AM; Shen J; Su T; Yao Y; Gao Y; Zhu Y; Shen X; Xie B
    Med Sci Monit; 2018 Aug; 24():5860-5873. PubMed ID: 30133427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept.
    Hong HK; Park YJ; Kim DK; Ryoo NK; Ko YJ; Park KH; Kim HM; Woo SJ
    Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):22. PubMed ID: 33196778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the IRE1α/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization.
    Liu L; Qi X; Chen Z; Shaw L; Cai J; Smith LH; Grant MB; Boulton ME
    Am J Pathol; 2013 Apr; 182(4):1412-24. PubMed ID: 23395094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
    FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of nitric-oxide synthase reduces choroidal neovascularization.
    Ando A; Yang A; Nambu H; Campochiaro PA
    Mol Pharmacol; 2002 Sep; 62(3):539-44. PubMed ID: 12181430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human VEGF165b inhibits experimental choroidal neovascularization.
    Hua J; Spee C; Kase S; Rennel ES; Magnussen AL; Qiu Y; Varey A; Dhayade S; Churchill AJ; Harper SJ; Bates DO; Hinton DR
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4282-8. PubMed ID: 20237252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
    Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X
    Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endothelial genesis inhibitor-8t (EDI-8t) against tumor growth].
    Zhou Q; Du P; Qian Y; Zhang Q; Feng B; Ding H; Gan R; Zhang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Dec; 26(12):1724-31. PubMed ID: 21387837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parstatin suppresses ocular neovascularization and inflammation.
    Huang H; Vasilakis P; Zhong X; Shen JK; Geronatsiou K; Papadaki H; Maragoudakis ME; Gartaganis SP; Vinores SA; Tsopanoglou NE
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5825-32. PubMed ID: 20538980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of choroidal and corneal pathologic neovascularization by Plgf1-de gene transfer.
    Tarallo V; Bogdanovich S; Hirano Y; Tudisco L; Zentilin L; Giacca M; Ambati J; De Falco S
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):7989-96. PubMed ID: 23139276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.
    Tan H; Mu G; Zhu W; Liu J; Wang F
    Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor.
    Miki K; Miki A; Matsuoka M; Muramatsu D; Hackett SF; Campochiaro PA
    Ophthalmology; 2009 Sep; 116(9):1748-54. PubMed ID: 19643496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
    Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
    J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitriol is a potent inhibitor of retinal neovascularization.
    Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice.
    Pan H; Nguyen NQ; Yoshida H; Bentzien F; Shaw LC; Rentier-Delrue F; Martial JA; Weiner R; Struman I; Grant MB
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2413-9. PubMed ID: 15223825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.